Business Description
enVVeno Medical Corp
NAICS : 339113
SIC : 3841
ISIN : US29415J1060
Share Class Description:
FRA:5HJ: Ordinary SharesDescription
enVVeno Medical Corp is a medical device company focused on the development of bioprosthetic (tissue-based) devices to improve the standard of care in the treatment of venous disease. Its product, the VenoValve, is a first-in-class, surgical implant being developed for the treatment of severe deep venous Chronic Venous Insufficiency (CVI).
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 42.14 | |||||
| Equity-to-Asset | 0.94 | |||||
| Debt-to-Equity | 0.02 | |||||
| Debt-to-EBITDA | -0.05 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 3/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 33.3 | |||||
| 3-Year EPS without NRI Growth Rate | 35.8 | |||||
| 3-Year FCF Growth Rate | 36.8 | |||||
| 3-Year Book Growth Rate | 7.5 | |||||
| Future 3-5Y EPS without NRI Growth Rate | 24.81 |
Momentum Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 75.9 | |||||
| 9-Day RSI | 65.16 | |||||
| 14-Day RSI | 57.55 | |||||
| 6-1 Month Momentum % | -35.93 | |||||
| 12-1 Month Momentum % | -35.37 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 22.01 | |||||
| Quick Ratio | 22.01 | |||||
| Cash Ratio | 21.7 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -73.7 | |||||
| Shareholder Yield % | 0.55 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -53.29 | |||||
| ROA % | -49.87 | |||||
| ROIC % | -974.07 | |||||
| ROC (Joel Greenblatt) % | -1504.56 | |||||
| ROCE % | -57.33 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 1.24 | |||||
| Price-to-Tangible-Book | 1.25 | |||||
| EV-to-EBIT | -0.5 | |||||
| EV-to-EBITDA | -0.51 | |||||
| EV-to-FCF | -0.7 | |||||
| Price-to-Net-Current-Asset-Value | 1.28 | |||||
| Price-to-Net-Cash | 1.3 | |||||
| Earnings Yield (Greenblatt) % | -200 | |||||
| FCF Yield % | -28.42 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
enVVeno Medical Corp Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | |||
| EPS (TTM) (€) | -1.181 | ||
| Beta | -1.03 | ||
| Volatility % | 87.69 | ||
| 14-Day RSI | 57.55 | ||
| 14-Day ATR (€) | 0.080046 | ||
| 20-Day SMA (€) | 2.688 | ||
| 12-1 Month Momentum % | -35.37 | ||
| 52-Week Range (€) | 2.38 - 6.05 | ||
| Shares Outstanding (Mil) | 17.54 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
enVVeno Medical Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
enVVeno Medical Corp Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
enVVeno Medical Corp Frequently Asked Questions
What is enVVeno Medical Corp(FRA:5HJ)'s stock price today?
The current price of FRA:5HJ is €2.94. The 52 week high of FRA:5HJ is €6.05 and 52 week low is €2.38.
When is next earnings date of enVVeno Medical Corp(FRA:5HJ)?
The next earnings date of enVVeno Medical Corp(FRA:5HJ) is 2025-02-28 Est..
Does enVVeno Medical Corp(FRA:5HJ) pay dividends? If so, how much?
enVVeno Medical Corp(FRA:5HJ) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers